Active Pharmacovigilance Surveillance: Drug Safety Monitoring for New Medicines and Novel Regimens of the National TB Program in the Philippines

On September 24, 2015 in Governance, Guidelines and SOPs, Pharmacovigilance, Philippines, Tuberculosis

The purpose of this standard operating procedure is to outline a step-by-step approach for undertaking active drug safety monitoring for the 9-month MDR-TB treatment regimen and other novel medications and regimens for TB and MDR-TB.

Files for Download: Other Files:
←
→